The average one-year price target for Xtant Medical Holdings (NYSEAM:XTNT) has been revised to $1.12 / share. This is a decrease of 18.52% from the prior estimate of $1.38 dated March 25, 2026. The price target is an average of many targets provided by analyst
The average one-year price target for Xtant Medical Holdings (NYSEAM:XTNT) has been revised to $1.12 / share. This is a decrease of 18.52% from the prior estimate of $1.38 dated March 25, 2026. The price target is an average of many targets provided by analyst
Shares of collaboration software company Atlassian (NASDAQ:TEAM) fell 8.1% in the afternoon session after Anthropic launched Managed Agents, autonomous AI systems that execute complex tasks.
Shares of collaboration software company Atlassian (NASDAQ:TEAM) fell 8.1% in the afternoon session after Anthropic launched Managed Agents, autonomous AI systems that execute complex tasks.